Try our Advanced Search for more refined results

Daiichi Sankyo Unit Says Rival Infringed IP As Trial Opens

By Dorothy Atkins ( July 12, 2021, 9:35 PM EDT) -- Counsel for a Daiichi Sankyo subsidiary told a California federal jury during trial openings on Monday that Novartis owes royalties for selling drugs that allegedly infringe its billion-dollar skin cancer treatment patents, while Novartis' attorney countered that his client should pay nothing because the patents are invalid. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies

Patents

The 2025 Summer Associates Survey

The recruiting process for law firm summer associates has transformed over the past few years. Find out how schools, law firms, and students have been working to adapt, as well as which firms topped students' wish lists, in the latest survey from Law360 Pulse.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!